Literature DB >> 25640106

Anticoagulation in the treatment of portovenous emboli after cyanoacrylate injection for a bleeding gastric varix.

Charlene Xian Wen Kwa1, Veronique Kiak Mien Tan, Hock Soo Ong.   

Abstract

We herein report the use of endoscopic n-butyl-2-cyanoacrylate injections to obliterate a gastric varix, which led to cyanoacrylate embolisation in the splenic and portal veins in a single patient. Cyanoacrylate embolisation is a known but uncommonly reported complication of endoscopic sclerotherapy. This case report illustrates the successful management of this complication (i.e. cyanoacrylate embolisation in the splenic and portal veins) with anticoagulation and analyses the presentation and management of other cases of cyanoacrylate embolisation reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25640106      PMCID: PMC4325574          DOI: 10.11622/smedj.2015016

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  15 in total

1.  Detection of thrombosis in the portal venous system: comparison of contrast-enhanced MR angiography with intraarterial digital subtraction angiography.

Authors:  B Kreft; H Strunk; S Flacke; M Wolff; R Conrad; J Gieseke; D Pauleit; R Bachmann; A Hirner; H H Schild
Journal:  Radiology       Date:  2000-07       Impact factor: 11.105

2.  Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation.

Authors:  Juan Turnes; Juan Carlos García-Pagán; Monica González; Carles Aracil; José Luís Calleja; Cristina Ripoll; Juan G Abraldes; Rafael Bañares; Cándido Villanueva; Agustín Albillos; Juan Ramón Ayuso; Rosa Gilabert; Jaime Bosch
Journal:  Clin Gastroenterol Hepatol       Date:  2008-12       Impact factor: 11.382

3.  Vascular disorders of the liver.

Authors:  Laurie D DeLeve; Dominique-Charles Valla; Guadalupe Garcia-Tsao
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

4.  Portal vein thrombosis complicating endoscopic variceal sclerotherapy. Convincing further evidence.

Authors:  J Korula; A Yellin; G C Kanel; P Nichols
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

5.  Hepatic failure requiring transplantation caused by portal vein embolism as a complication of N-buty-2-cyanoacrylate injection for a bleeding gastric varix.

Authors:  Kee Myung Lee; Young Bae Kim; Sung Jae Sin; Jae Chul Hwang; Byung Moo Yoo; Jae Yeon Jung; Jin Hong Kim; Sung Won Cho
Journal:  Gastrointest Endosc       Date:  2009-04       Impact factor: 9.427

6.  Portal-vein embolization after sclerotherapy treatment of bleeding gastric varices: report of a case with long-term follow-up.

Authors:  Kai-Lun Shih; Hsu-Heng Yen; Maw-Soan Soon
Journal:  Gastrointest Endosc       Date:  2009-01-18       Impact factor: 9.427

7.  Low incidence of complications from endoscopic gastric variceal obturation with butyl cyanoacrylate.

Authors:  Liu-Fang Cheng; Zhi-Qiang Wang; Chang-Zheng Li; Wu Lin; Anthony E T Yeo; Bo Jin
Journal:  Clin Gastroenterol Hepatol       Date:  2010-05-31       Impact factor: 11.382

8.  N-2-butyl-cyanoacrylate for bleeding gastric varices: a United States pilot study and cost analysis.

Authors:  Bruce D Greenwald; Stephen H Caldwell; Elizabeth E Hespenheide; James T Patrie; Jeffrey Williams; Kenneth F Binmoeller; Lysa Woodall; Oleh Haluszka
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

9.  Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy.

Authors:  B Condat; F Pessione; M Helene Denninger; S Hillaire; D Valla
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

10.  Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients.

Authors:  S K Sarin; D Lahoti; S P Saxena; N S Murthy; U K Makwana
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.